Increased production of lnterleukin-1β and lnterleukin-1 receptor antagonist by peripheral blood mononuclear cells in undialyzed chronic renal failure

Nephron

Volumn 76, Issue 1, 1997, Pages 26-31

  Higuchi, Terumi ^a   Yamamoto, Chii ^a   Kano, Tsutomu ^a   Mizuno, Mari ^a   Takahashi, Susumu ^a   Kanmatsuse, Katsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic renal failure; Hemodialysis; Interleukin 1 receptor antagonist; Interleukin 1 beta; ; Peripheral blood mononuclear cells

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE;

ADULT; AGED; ARTICLE; CELL CULTURE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; KIDNEY FAILURE, CHRONIC; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; RENAL DIALYSIS; SIALOGLYCOPROTEINS;

EID: 0031004562     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190136     Document Type: Article

References (30)

1. Lonnemann G., Van Der Mecr JWM, Cannon JG., Dinarcllo CA, Koch KM, Granolleras C, Deschodt G, Shaldon S: Induction of tumor necrosis factor during extracorporeal blood purification., N Engl J Med 1987;317:963-964.
2. Luger A, Kovarik J., Stummvoll HK., Urbanska A, Luger TA: Blood-membrane interaction in hemodialysis leads to increased cytokine production., Kidney Int 1987:32:84-88.
3. Herbclin A, Nguyen AT., Zingraff J., Urena P, Dcscamp-Latscha B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor a., Kidney lnt 1990;37: 116-125.
4. Herbelin A., Urena P., Nguyen AT., Zingraff J, Dcscamp-Latscha B: Elevated circulating levels of interlcukin-6 in patients with chronic renal failure., Kidney lnt 1991;39:954-960.
5. Cavaillon JM, Poignet JL, Fitting C., Delons S: Serum interlcukin-6 in long-term hemodia-lyzcd patients., Nephron 1992;60:307-313.
6. Nakahama H., Tanaka Y., Shirai D., Miyazaki M., Imai N, Yokokawa T., Okada M, Kubori S: Plasma interleukin-6 levels in continuous ambulatory peritoneal and hemodialysis patients., Nephron 1992:61:132-134.
7. Paydas S, Aksu HSZ., Paydas S, Karademir M., Gursay AA: Plasma levels of tumor necrosis factor during hemodialysis., Nephron 1991;57: 477-478.
8. Seckingcr P., Lowenthal JW., Williamson K., Dayer JM., Macdonald HR: A urine inhibitor of interleukin I activity that blocks ligand binding., J Immunol 1987:139:1546-1549.
9. Engelmann H., Aderka D., Rubinstein M., Tor-man D., Wallach D: A tumor necrosis factorbinding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity., J Biol Chem 1989;264:11974-11980.
10. Lantz M, Gullberg U., Nilsson E, Olsson I: Characterization in vitro of a human tumor necrosis factor-binding protein: A soluble form of a tumor necrosis factor receptor., J Clin Invest 1990;86:1396-1402.
11. Pereira BJG., Shapiro L, King AJ., Falagas ME, Strom JA., Dinarello CA: Plasma levels of IL-lp, TNFa and their specific inhibitors in un-dialyzcd chronic renal failure, CAPD and hemodialysis patients., Kidney Int 1994:45:890-896.
12. Brockhaus M., Bar-Khayim Y., Gurwicz S, Frcnsdorf T A., Haran N: Plasma tumor necrosis factor soluble receptors in chronic renal failure., Kidney Int 1992;42:663-667.
13. Pertosa G, Gcsualdo L, Tarantino EA., Ranieri E, Bottalico D, Schcna FP: Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells., Kidney Int 1993:43(suppl 39): 149-153.
14. Hcrbelin A, Urena P., Nguyen AT, Zingraff J, Descamps-Latscha B: Influence of first and long-term dialysis on uraemia-associated increased basal production of interleukin-1 and tumor necrosis factor a by circulating monocytes., Nephrol Dial Transplant 1991:6:349-357.
15. Pereira BJG., Poutsiaka DD., Strom JA, Na-rayan G., Levey AS, King AJ, Dinarello CA: In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD., Kidney Int 1992:42:1419-1424.
16. Leimenstoll G, Zabel P., Birkner T., Heyl K., Prcusse D, Niedcrmayer W: Effect of renal function on cytokin secretion of monocytes and lymphocytes., Nephrol Dial Transplant 1994:9:493-498
17. Lonnemann G., Floege J., Schindler R., Behmc T, Lcnzncr B., Schaldon S., Koch KM: Passage of cytokine-inducing E, coli fragments (CEF) through hemodialysis (HD) membranes., Kidney Int 1989:35:254.
18. Lonnemann G, Behmc TC, Lenzner B., Floege J., Schulze M., Colton CK., Koch KM., Shaldon S: Permeability of dialyzer membranes to TNFa-inducing substances derived from water bacteria., Kidney Int 1992;42:61-68.
19. Bingel M., Lonnemann G., Koch KM., Dinarello CA, Shaldon S: Enhancement of in vitro human interleukin-1 production by sodium acetate., Lancet 1987;vol i: 14-16.
20. Schindler R., Lonnemann G., Shaldon S, Koch KM., Dinarello CA: Transcription, not synthesis., of interleukin-1 and tumor necrosis factor by complement., Kidney Int 1990;37:85-93.
21. Megc JL., Brunet P., Capo C., Dussol B., Bon-grand P., Borland Y: Non-endotoxinic tumor necrosis factor-a-inducing factors in haemodialysis., Nephrol Dial Transplant 1994:9:1606-1610.
22. Dinarello CA: Cytokines agents provocateurs in hemodialysis? Kidney Int 1992:41:683-694.
23. Miyata T., lnagi R., lida Y., Sato M., Yamada N., Oda O, Maeda K., Sco H: Involvement of ()*o microglobulin modified with advanced glyca-tion end products in the pathogenesis of hemodialysis-associated amyloidosis., J Clin Invest 1994;93:521-528.
24. Haeffner-Cavillon N., Jahns G., Poignet JL., Ka-zatchkine M: Induction of interleukin-1 during hemodialysis., Kidney Int 1993:43(suppl 39): 139-143.
25. Canivet E., Lavaud S, Wong T, Gucnounou M., Willemin JC., Potron G., Chanard J: Cupro-phanc but not synthetic membrane induces increases in scrum tumor necrosis factor-alpha levels during hemodialysis., Am J Kidney Dis 1994;23:41-46.
26. Fisher E, Marano MA., Barber AE., Hudson A., Lcc K., Rock CS, Hawes AS, Thompson RC., Hayes TJ., Anderson TD., Benjamin WR, Lowry SF., Moldawer LL: Comparison between effects of interlcukin-ra administration and sublcthal endotoxemia in primates., Am J Physiol 1991;261 R442-452.
27. Granowitz EV, Santos A., Poutsiaka DD., Cannon JG., Wilmore DA, Dinarello CA: Circulating interleukin-1 reepetor antagonist levels during experimental endotoxemia in human., Lancet 1991:338:1423-1424.
28. Arcnd WP., Wclgus HG, Thompson RC., Eiscn-berg SP: Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist., J Clin Invest 1990:85:1694-1697.
29. McIntyre KW., Stepan GJ., Kolinsky DK., Benjamin WR, Plocinski JM, Kaffka KL., C'ampen RA., Chizzonitc RA., Kilian PL: Interleukin-1 receptor antagonist blocks acute inflammatory response to IL-I and other agents in vitro., J Exp Med 1991:173:931-939.
30. Dinarello CA: Interleukin-1 and interleukin-1 antagonism., Blood 1991;77:1627-1652